Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 14, 2024Open Access

Plasma glucosylceramide levels are regulated by ATP10D and are not involved in Parkinson's disease pathogenesis.

View Full Paper
Ask AI
Bookmark
Share

Authors

ESEmma N. SomervilleMontreal Neurological Institute and HospitalAJAlva JamesCBChristian BeetzCentogene (Germany)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Somerville et al. (2024) studied this question.

synapsesocial.com/papers/68e5891fb6db643587524d5fhttps://doi.org/10.1101/2024.09.13.24313644
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program2021 · 2,386 citations
  2. 2Genetic Determinants of Circulating Sphingolipid Concentrations in European Populations2009 · 221 citations
  3. 3Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies2019 · 110 citations
  4. 4Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia2019 · 251 citations
  5. 5The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons2023 · 12 citations